# A Study of IMC008 for Advanced Solid Tumors

> **NCT05837299** · PHASE1 · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** IMC008

## Key facts

- **NCT ID:** NCT05837299
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-02
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2023-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05837299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05837299, "A Study of IMC008 for Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05837299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*